JIDEYTRO

Serial Number 98876370
686

Registration Progress

Application Filed
Nov 27, 2024
Under Examination
Approved for Publication
Jul 29, 2025
Published for Opposition
Jul 29, 2025
Registered

Attorney Assistance

Notice of Publication
Due: Aug 28, 2025 26 days

Trademark Image

JIDEYTRO

Basic Information

Serial Number
98876370
Filing Date
November 27, 2024
Published for Opposition
July 29, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
686
Status Date
Jul 29, 2025
Application
Pending
Classes
005

Rights Holder

Nuvalent, Inc.

03
Address
One Broadway, 14th Floor
Cambridge, MA 02142

Ownership History

Nuvalent, Inc.

Original Applicant
03
Cambridge, MA

Nuvalent, Inc.

Owner at Publication
03
Cambridge, MA

Legal Representation

Attorney
Joshua S. Jarvis

USPTO Deadlines

Next Deadline
26 days remaining
Notice of Publication
Due Date
August 28, 2025
Extension Available
Until September 28, 2025
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

13 events
Date Code Type Description Documents
Jul 29, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jul 29, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 23, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jun 20, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jun 20, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 20, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jun 20, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
May 20, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
May 20, 2025 CNRT R NON-FINAL ACTION WRITTEN Loading...
May 20, 2025 GNRT F NON-FINAL ACTION E-MAILED Loading...
May 20, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
May 15, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 27, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations and pharmaceutical products for use in oncology diseases and disorders

Classification

International Classes
005